Analysts New Coverage

Iron Mountain Incorporated (Delaware) REIT (IRM) Earns Hold Rating from Analysts at Deutsche Bank AG

Iron Mountain Incorporated (Delaware) REIT (IRM) Earns Hold Rating from Analysts at Deutsche Bank AG

Equities research analysts at Deutsche Bank AG began coverage on shares of Iron Mountain Incorporated (Delaware) REIT (NYSE:IRM) in a research note issued on Wednesday, The Fly reports. The firm set a “hold” rating on the stock. Separately, Zacks Investment Research upgraded shares of Iron Mountain Incorporated (Delaware) REIT from a “strong sell” rating to […]
ARRIS International PLC (ARRS) Earns Market Perform Rating from Analysts at Northland Securities

ARRIS International PLC (ARRS) Earns Market Perform Rating from Analysts at Northland Securities

Analysts at Northland Securities started coverage on shares of ARRIS International PLC (NASDAQ:ARRS) in a report released on Tuesday. The firm set a “market perform” rating and a $30.00 price target on the stock. Northland Securities’ target price indicates a potential upside of 0.17% from the stock’s current price. A number of other equities analysts […]
ARRIS International plc (ARRS) Coverage Initiated by Analysts at Northland Securities

ARRIS International plc (ARRS) Coverage Initiated by Analysts at Northland Securities

Investment analysts at Northland Securities started coverage on shares of ARRIS International plc (NDAQ:ARRS) in a research report issued on Tuesday, StockTargetPrices.com reports. The brokerage set a “market perform” rating and a $30.00 price target on the stock. Shares of ARRIS International plc (NDAQ:ARRS) traded down 0.83% during mid-day trading on Tuesday, hitting $29.95. The […]
AnaptysBio Inc (ANAB) Receives New Coverage from Analysts at JMP Securities

AnaptysBio Inc (ANAB) Receives New Coverage from Analysts at JMP Securities

Research analysts at JMP Securities began coverage on shares of AnaptysBio Inc (NDAQ:ANAB) in a report issued on Tuesday, StockTargetPrices.com reports. The firm set a “mkt outperform” rating and a $45.00 price target on the stock. Shares of AnaptysBio (NDAQ:ANAB) traded down 0.67% during midday trading on Tuesday, hitting $23.73. The stock had a trading […]
AnaptysBio Inc (ANAB) Coverage Initiated by Analysts at Credit Suisse Group

AnaptysBio Inc (ANAB) Coverage Initiated by Analysts at Credit Suisse Group

Stock analysts at Credit Suisse Group started coverage on shares of AnaptysBio Inc (NDAQ:ANAB) in a report issued on Tuesday, StockTargetPrices.com reports. The firm set an “outperform” rating and a $34.00 price target on the stock. ANAB has been the topic of a number of other reports. JMP Securities initiated coverage on shares of AnaptysBio […]
KINNEVIK INV AB SER'B'NPV (KINNF) Now Covered by Analysts at Deutsche Bank AG

KINNEVIK INV AB SER'B'NPV (KINNF) Now Covered by Analysts at Deutsche Bank AG

Equities research analysts at Deutsche Bank AG began coverage on shares of KINNEVIK INV AB SER'B'NPV (OTC:KINNF) in a research note issued to investors on Tuesday, StockTargetPrices.com reports. The brokerage set a “buy” rating on the stock. KINNEVIK INV AB SER'B'NPV (OTC:KINNF) remained flat at $25.10 on Tuesday. The stock’s 50-day moving average is $27.50 […]
Jounce Therapeutics Inc (JNCE) Coverage Initiated at J P Morgan Chase & Co

Jounce Therapeutics Inc (JNCE) Coverage Initiated at J P Morgan Chase & Co

Equities research analysts at J P Morgan Chase & Co started coverage on shares of Jounce Therapeutics Inc (NDAQ:JNCE) in a research report issued on Tuesday, StockTargetPrices.com reports. The brokerage set an “overweight” rating and a $28.00 price target on the stock. A number of other analysts have also commented on JNCE. Wells Fargo & […]
Miragen Therapeutics, Inc. (MGEN) Now Covered by Analysts at Wedbush

Miragen Therapeutics, Inc. (MGEN) Now Covered by Analysts at Wedbush

Equities research analysts at Wedbush assumed coverage on shares of Miragen Therapeutics, Inc. (NDAQ:MGEN) in a research note issued on Tuesday, StockTargetPrices.com reports. The firm set an “outperform” rating and a $19.00 price target on the stock. Shares of Miragen Therapeutics (NDAQ:MGEN) traded up 18.05% during trading on Tuesday, reaching $13.93. The company’s stock had […]
Obseva SA (OBSV) Now Covered by Analysts at Credit Suisse Group

Obseva SA (OBSV) Now Covered by Analysts at Credit Suisse Group

Credit Suisse Group initiated coverage on shares of Obseva SA (NDAQ:OBSV) in a research note issued to investors on Tuesday, StockTargetPrices.com reports. The firm set an “outperform” rating and a $27.00 price target on the stock. A number of other equities research analysts also recently commented on the company. Leerink Swann started coverage on Obseva […]
Credit Suisse Group Initiates Coverage on Rev Group Inc (REVG)

Credit Suisse Group Initiates Coverage on Rev Group Inc (REVG)

Analysts at Credit Suisse Group began coverage on shares of Rev Group Inc (OTC:REVG) in a research note issued to investors on Tuesday, StockTargetPrices.com reports. The firm set an “outperform” rating and a $33.00 price target on the stock. A number of other equities research analysts have also weighed in on the company. Deutsche Bank […]
Rev Group Inc (REVG) Earns Outperform Rating from Analysts at Wells Fargo & Company

Rev Group Inc (REVG) Earns Outperform Rating from Analysts at Wells Fargo & Company

Equities researchers at Wells Fargo & Company assumed coverage on shares of Rev Group Inc (OTC:REVG) in a research note issued on Tuesday, StockTargetPrices.com reports. The firm set an “outperform” rating on the stock. Several other research analysts have also commented on the stock. Deutsche Bank AG assumed coverage on shares of Rev Group in […]
Rev Group Inc (REVG) Research Coverage Started at Stifel Nicolaus

Rev Group Inc (REVG) Research Coverage Started at Stifel Nicolaus

Equities researchers at Stifel Nicolaus started coverage on shares of Rev Group Inc (OTC:REVG) in a research report issued on Tuesday, StockTargetPrices.com reports. The brokerage set a “buy” rating and a $33.00 price target on the stock. Other analysts have also recently issued research reports about the stock. Deutsche Bank AG assumed coverage on shares […]
Robert W. Baird Begins Coverage on Rev Group Inc (REVG)

Robert W. Baird Begins Coverage on Rev Group Inc (REVG)

Equities researchers at Robert W. Baird began coverage on shares of Rev Group Inc (OTC:REVG) in a report issued on Tuesday, StockTargetPrices.com reports. The brokerage set an “outperform” rating and a $31.00 price target on the stock. Other equities research analysts have also recently issued reports about the company. Goldman Sachs Group, Inc. (The) started […]
Rev Group Inc (REVG) Now Covered by Morgan Stanley

Rev Group Inc (REVG) Now Covered by Morgan Stanley

Equities researchers at Morgan Stanley assumed coverage on shares of Rev Group Inc (OTC:REVG) in a research report issued to clients and investors on Tuesday, StockTargetPrices.com reports. The firm set an “equal weight” rating and a $30.00 price target on the stock. A number of other brokerages have also recently issued reports on REVG. Deutsche […]
Rev Group Inc (REVG) Now Covered by Goldman Sachs Group, Inc. (The)

Rev Group Inc (REVG) Now Covered by Goldman Sachs Group, Inc. (The)

Analysts at Goldman Sachs Group, Inc. (The) initiated coverage on shares of Rev Group Inc (OTC:REVG) in a research note issued to investors on Tuesday, StockTargetPrices.com reports. The brokerage set a “neutral” rating and a $24.00 price target on the stock. Separately, Deutsche Bank AG assumed coverage on Rev Group in a research report on […]
Deutsche Bank AG Initiates Coverage on Rev Group Inc (REVG)

Deutsche Bank AG Initiates Coverage on Rev Group Inc (REVG)

Stock analysts at Deutsche Bank AG started coverage on shares of Rev Group Inc (OTC:REVG) in a research report issued to clients and investors on Tuesday, StockTargetPrices.com reports. The brokerage set a “hold” rating and a $30.00 price target on the stock. Rev Group (OTC:REVG) traded down 3.41% during trading on Tuesday, reaching $26.65. 425,005 […]
Obseva SA (OBSV) Coverage Initiated at Leerink Swann

Obseva SA (OBSV) Coverage Initiated at Leerink Swann

Analysts at Leerink Swann initiated coverage on shares of Obseva SA (NDAQ:OBSV) in a note issued to investors on Tuesday, StockTargetPrices.com reports. The brokerage set an “outperform” rating and a $21.00 price target on the stock. Separately, Jefferies Group LLC started coverage on shares of Obseva SA in a report on Tuesday. They set a […]
AnaptysBio Inc (ANAB) Now Covered by Wedbush

AnaptysBio Inc (ANAB) Now Covered by Wedbush

Research analysts at Wedbush assumed coverage on shares of AnaptysBio Inc (NDAQ:ANAB) in a report issued on Tuesday, StockTargetPrices.com reports. The brokerage set an “outperform” rating and a $28.00 price target on the stock. Other research analysts also recently issued reports about the company. JMP Securities started coverage on AnaptysBio in a research note on […]
AnaptysBio Inc (ANAB) Now Covered by Analysts at Stifel Nicolaus

AnaptysBio Inc (ANAB) Now Covered by Analysts at Stifel Nicolaus

Equities research analysts at Stifel Nicolaus assumed coverage on shares of AnaptysBio Inc (NDAQ:ANAB) in a report issued on Tuesday, StockTargetPrices.com reports. The brokerage set a “buy” rating and a $30.00 price target on the stock. Separately, JMP Securities started coverage on AnaptysBio in a research report on Tuesday. They issued a “mkt outperform” rating […]
Obseva SA (OBSV) Now Covered by Analysts at Jefferies Group LLC

Obseva SA (OBSV) Now Covered by Analysts at Jefferies Group LLC

Investment analysts at Jefferies Group LLC started coverage on shares of Obseva SA (NDAQ:OBSV) in a research note issued on Tuesday, StockTargetPrices.com reports. The brokerage set a “buy” rating and a $21.00 price target on the stock. Obseva SA (NDAQ:OBSV) traded down 0.45% during mid-day trading on Tuesday, hitting $13.15. 110,919 shares of the stock […]
Jounce Therapeutics Inc (JNCE) Now Covered by Wells Fargo & Company

Jounce Therapeutics Inc (JNCE) Now Covered by Wells Fargo & Company

Wells Fargo & Company assumed coverage on shares of Jounce Therapeutics Inc (NDAQ:JNCE) in a research note issued on Tuesday, StockTargetPrices.com reports. The brokerage set an “outperform” rating on the stock. Separately, Robert W. Baird started coverage on shares of Jounce Therapeutics in a research note on Tuesday. They set an “outperform” rating and a […]
Jounce Therapeutics Inc (JNCE) Coverage Initiated at Robert W. Baird

Jounce Therapeutics Inc (JNCE) Coverage Initiated at Robert W. Baird

Analysts at Robert W. Baird assumed coverage on shares of Jounce Therapeutics Inc (NDAQ:JNCE) in a note issued to investors on Tuesday, StockTargetPrices.com reports. The brokerage set an “outperform” rating and a $30.00 price target on the stock. Shares of Jounce Therapeutics (NDAQ:JNCE) traded up 2.61% during mid-day trading on Tuesday, hitting $20.42. 160,562 shares […]
Cree, Inc. (CREE) Receives New Coverage from Analysts at J P Morgan Chase & Co

Cree, Inc. (CREE) Receives New Coverage from Analysts at J P Morgan Chase & Co

Equities researchers at J P Morgan Chase & Co began coverage on shares of Cree, Inc. (NASDAQ:CREE) in a report released on Tuesday. The firm set an “overweight” rating and a $30.00 price target on the LED producer’s stock. J P Morgan Chase & Co’s target price would suggest a potential upside of 10.54% from […]
Endo International PLC (ENDP) Research Coverage Started at Canaccord Genuity

Endo International PLC (ENDP) Research Coverage Started at Canaccord Genuity

Equities research analysts at Canaccord Genuity began coverage on shares of Endo International PLC (NASDAQ:ENDP) in a research note issued on Tuesday, The Fly reports. The firm set a “hold” rating on the stock. Several other research analysts also recently commented on ENDP. Royal Bank Of Canada cut their price target on shares of Endo […]
Canaccord Genuity Begins Coverage on Perrigo Company plc (PRGO)

Canaccord Genuity Begins Coverage on Perrigo Company plc (PRGO)

Equities research analysts at Canaccord Genuity began coverage on shares of Perrigo Company plc (NYSE:PRGO) in a research report issued to clients and investors on Tuesday, The Fly reports. The brokerage set a “buy” rating on the stock. PRGO has been the subject of several other research reports. RBC Capital Markets set a $92.00 price […]
Content on this website is not meant to be a recommendation or an offer to buy or sell any security. Click here to read our full disclaimer.